Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammatory myopathies.

W J Kingston1, R T Moxley

  • 1University of Rochester Medical Center, New York.

Neurologic Clinics
|August 1, 1988
PubMed
Summary
This summary is machine-generated.

Inflammatory myopathies, including polymyositis and inclusion body myositis, present with muscle weakness and inflammation. Treatment typically involves prednisone, with other immunosuppressants added if needed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Survival patterns and cancer determinants in families with myotonic dystrophy type 1.

European journal of neurology·2018
Same author

Pigmentation phenotype, photosensitivity and skin neoplasms in patients with myotonic dystrophy.

European journal of neurology·2017
Same author

Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.

Neurology·2010
Same author

Distal myasthenia gravis with a decrement, an increment, and denervation.

Journal of clinical neuromuscular disease·2008
Same author

Quantitative analysis of the "warm-up" phenomenon in myotonic dystrophy type 1.

Muscle & nerve·2005
Same author

Practice parameter: corticosteroid treatment of Duchenne dystrophy [RETIRED]: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

Neurology·2005

Area of Science:

  • Neurology
  • Immunology
  • Pathology

Background:

  • Inflammatory myopathies are a diverse group of neuromuscular disorders.
  • They are characterized by muscle weakness, elevated muscle enzymes, and specific biopsy findings.
  • Distinct subtypes like inclusion body myositis have unique clinical and pathological features.

Purpose of the Study:

  • To review the heterogeneity of inflammatory myopathies.
  • To highlight differences in clinical presentation, pathology, and pathogenesis.
  • To discuss current therapeutic approaches.

Main Methods:

  • Review of recent evidence on inflammatory myopathies.
  • Comparison of clinical features, diagnostic criteria, and pathological findings.
  • Analysis of proposed pathogenetic mechanisms and treatment strategies.

Related Experiment Videos

Main Results:

  • Inflammatory myopathies typically cause proximal muscle weakness.
  • Inclusion body myositis shows distal weakness and characteristic rimmed vacuoles on biopsy.
  • Autoimmune and potential viral factors are implicated in pathogenesis.
  • Dermatomyositis involves vascular damage, while polymyositis and inclusion body myositis show direct muscle fiber attack.

Conclusions:

  • Understanding the heterogeneity is crucial for diagnosis and management.
  • Inclusion body myositis may be resistant to standard therapies.
  • Prednisone is the first-line treatment, with azathioprine or methotrexate as second-line options.